SCM
AVNS

Shelton Capital Management’s Avanos Medical AVNS Stock Holding History

Shelton Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,497
Closed -$240K – 792
2018
Q3 		$240K Sell
3,497
-25
-0.7% -$1.61K 0.01% 738
2018
Q2 		$202K Buy
+3,522
New +$186K 0.01% 808
2015
Q3 		– Sell
-6,918
Closed -$280K – 746
2015
Q2 		$280K Sell
6,918
-365
-5% -$16.4K 0.03% 609
2015
Q1 		$358K Hold
7,283
– – 0.04% 517
2014
Q4 		$331K Buy
+7,283
New +$286K 0.04% 537

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Shelton Capital Management's AVNS Position: Q4 2018 in Review

Shelton Capital Management sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 3,497 shares — an estimated $240K sold.

Shelton Capital Management first reported a position in AVNS in Q4 2014 and held it in 5 quarters. The position peaked at $358K in Q1 2015. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Shelton Capital Management reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Shelton Capital Management sold 3,497 Avanos Medical shares in Q4 2018, an estimated $240K.
  • Shelton Capital Management first reported a position in Avanos Medical in Q4 2014 and held it in 5 quarters.
  • Shelton Capital Management's Avanos Medical position peaked at $358K in Q1 2015.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Shelton Capital Management's 13F filing for Q4 2018, filed 31 Jan 2019.